Inventor · disambiguated record
Sumayah Jamal
Also filed as: JAMAL SUMAYAH
9 granted patents·6 pending applications·46 citations·filing 1999–2024
88Inventor score
Top patents by PatentIndex Score
15 records- 0192US11338014B2Methods and compositions for treatment of endothelin B receptor expressing tumorsENB THERAPEUTICS INC·Filed 2020·Granted May 24, 2022·3 cites·11 claims
- 0291US10695400B2Compositions and methods for treating cancers associated with ETBR activationENB THERAPEUTICS INC·Filed 2016·Granted Jun 30, 2020·6 cites·8 claims
- 0391US10435434B2Deuterated compounds, compositions, and methods for treating cancers associated with ETBR activationENB THERAPEUTICS INC·Filed 2019·Granted Oct 8, 2019·5 cites·19 claims
- 0491US8597645B2Cancer treatment with endothelin receptor antagonistsSCHNEIDER ROBERT·Filed 2011·Granted Dec 3, 2013·8 cites·6 claims
- 0590US11066442B2Deuterated compounds, compositions, and methods for treating cancers associated with ETBR activationENB THERAPEUTICS INC·Filed 2019·Granted Jul 20, 2021·4 cites·12 claims
- 0687US12077604B2Deuterated compounds, compositions, and methods for treating cancers associated with ETBR activationENB THERAPEUTICS INC·Filed 2021·Granted Sep 3, 2024·1 cites·13 claims
- 0783US9125897B2Cancer treatment with endothelin receptor antagonistsUNIV NEW YORK·Filed 2013·Granted Sep 8, 2015·3 cites·10 claims
- 0883US8067000B2Cancer treatment with endothelin receptor antagonistsSCHNEIDER ROBERT J·Filed 2009·Granted Nov 29, 2011·6 cites·18 claims
- 0982US2024360173A1Deuterated compounds, compositions, and methods for treating cancers associated with etbr activationENB THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1063US7566452B1Cancer treatment with endothelin receptor antagonistsUNIV NEW YORK·Filed 1999·Granted Jul 28, 2009·10 cites·16 claims
- 1160US2019314444A1Etbr antagonist compounds, compositions, and usesENB THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 1259US2021077562A1Etbr antagonist compounds, compositions, and usesENB THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1349US2022265628A1Treatment of urothelial and kidney cancers by use of endothelin b receptor antagonistsENB THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1448US2020268829A1Methods and compositions for inhibiting metastases of an endothelin b receptor expressing cancerENB THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 1548US2020289495A1Methods of inhibiting endothelin b receptor expressing tumor metastasesENB THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Sumayah Jamal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →